Immune-Related Adverse Events
13 clinical trials · Condition
◉ Watch Immune-Related Adverse Events
| Record | Firm | Date |
|---|---|---|
| ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment (NCT05414552) | University of Freiburg | 2021-06-01 |
| Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs) (NCT04375228) | Columbia University | 2020-09-25 |
| PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study (NCT04115410) | Sungkyunkwan University | 2020-07-01 |
| A Single-cell Approach to Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint Blockade (NCT04807127) | Universitaire Ziekenhuizen KU Leuven | 2020-02-01 |
| Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors (NCT07357636) | Shantou University Medical College | 2019-01-10 |
Track Immune-Related Adverse Events automatically
Every clearance here is in the API, with alerts when new ones post.